Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and ...

Boston Scientific Corporation develops ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can ... worsening heart failure in people with CIEDs – pacemakers, implantable cardioverter defibrillators ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients.

Although some studies have demonstrated that, given appropriate precautions, MRI can be safely performed in patients with selected implantable pacemakers, MRI in pacemaker patients is still ...

The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI ...

The Accent MRI pacemaker, with the Tendril MRI lead, is an MRI conditional system, offering safe performance of a full-body MRI scan on the patient using a 1.5 T (Tesla) field-strength MRI scanner.

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.